EULAR recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases, including Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Citation
Drosos , G C , Vedder , D , Houben , E , Boekel , L , Atzeni , F , Badreh , S , Boumpas , D T , Brodin , N , Bruce , I N , González-Gay , M Á , Jacobsen , S , Kerekes , G , Marchiori , F , Mukhtyar , C , Ramos-Casals , M , Sattar , N , Schreiber , K , Sciascia , S , Svenungsson , E , Szekanecz , Z , Tausche , A-K , Tyndall , A , van Halm , V , Voskuyl , A , Macfarlane , G , Ward , M M , Nurmohamed , M T & Tektonidou , M G 2022 , ' EULAR recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases, including Systemic Lupus Erythematosus and Antiphospholipid Syndrome ' , Annals of the Rheumatic Diseases .
Rights
This is the accepted version of [full cite]. Version of record can be found at [DOI]